Mexiletine Hydrochloride

盐酸美西律

Report date: 2023/04/25 15:42:38
NME

Base Information

Drug NameMexiletine Hydrochloride
Drug Alias Name盐酸麦西雷丁脉律定脉克定美西津慢心律 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsPainTachycardiaArrhythmias, Cardiac +[14] 
Global Approved IndicationsTachycardiaArrhythmias, CardiacMyotonic Disorders +[4] 
Approved Indications in ChinaVentricular Arrhythmia
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesTaiyo Co LtdLupin Europe GmbhLupin Atlantis Holdings Sa +[5] 
Inactive CompaniesRadboud University Medical CenterUniversity Of RochesterNational Institute Of Neurological Disorders And Stroke +[6] 
Active IndicationsTachycardiaArrhythmias, CardiacMyotonia +[6] 
Inactive IndicationsPainBlepharospasmDiabetic Neuropathies +[8] 

Other Information

ATC CodeC01BB02
Related LinksWikipediaDrugBankKEGG